Cargando...
Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis
BACKGROUND: Growth hormone (GH) treatment is currently recommended in Prader-Willi syndrome (PWS) patients. OBJECTIVES: To evaluate the impact (efficacy and safety) of the use of recombinant human GH (rhGH) as a treatment for PWS. METHOD: We performed a systematic review and, where possible, meta-an...
Guardado en:
| Publicado en: | BMJ Paediatr Open |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7213882/ https://ncbi.nlm.nih.gov/pubmed/32411831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjpo-2019-000630 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|